{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:03Z","timestamp":1791828543277,"version":"4.3.4"},"reference-count":45,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpem-2019-0345_s_999_w2aab3b7c11b1b6b1aab1c17b1Aa\">\n                  <jats:title id=\"d679415e39371_w2aab3b7c11b1b6b1aab1c17b1aAa\">Background<\/jats:title>\n                  <jats:p>Congenital adrenal hyperplasia (CAH) is a chronic disorder causing adrenal insufficiency and hyperandrogenism affecting the quality of life (QOL). The objective of the study was to assess the health-related QOL (HRQOL) in Egyptian children and adolescents with CAH and to identify factors affecting it.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2019-0345_s_998_w2aab3b7c11b1b6b1aab1c17b2Aa\">\n                  <jats:title id=\"d679415e39379_w2aab3b7c11b1b6b1aab1c17b2aAa\">Methods<\/jats:title>\n                  <jats:p>This cross-sectional study included 200 CAH patients (with 21-hydroxylase deficiency [21-OHD]) who were assessed according to their age, sex, clinical phenotype, timing of genitoplasty, hospital admissions within the last year, compliance to treatment, regularity of follow-up, presence of complications and hormonal control. HRQOL was assessed using the World Health Organization (WHO)QOL-BREF questionnaire with four domains analyzed independently including physical, psychological, social and environmental domains, with higher scores indicating better QOL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2019-0345_s_997_w2aab3b7c11b1b6b1aab1c17b3Aa\">\n                  <jats:title id=\"d679415e39387_w2aab3b7c11b1b6b1aab1c17b3aAa\">Results<\/jats:title>\n                  <jats:p>The study included 140 females and 60 males with a mean age of 6.6\u2009\u00b1\u20094.5 years, and 88% were salt-wasting (SW). Older patients had significantly lower QOL scores (r\u2009=\u2009\u2212\u20090.151, p\u2009=\u20090.033). The physical domain correlated significantly with the degree of virilization (r\u2009=\u2009\u2212\u20090.491, p\u2009=\u20090.001) and frequency of hospitalization (r\u2009=\u2009\u2212\u20090.495, p\u2009&lt;\u20090.001). The psychological domain was affected by age (r\u2009=\u2009\u2212\u20090.157, p\u2009=\u20090.026) and timing of genitoplasty (r\u2009=\u2009\u2212\u20090.326, p\u2009=\u20090.001), while the social domain was affected by age (r\u2009=\u2009\u22120.277, p\u2009&lt;\u20090.005) and pubertal stage (r\u2009=\u2009\u2212\u20090.195, p\u2009=\u20090.006). Females had lower scores at the psychological domain (p\u2009&lt;\u20090.001), whereas males had lower scores at the physical domain (p\u2009=\u20090.003). Salt-losing patients had lower scores at the physical domain (p\u2009=\u20090.001). Patients with good hormonal control had higher scores at the physical domain (p\u2009=\u20090.03). Genitoplasty affected both psychological and social domains (p\u2009=\u20090.003 and 0.01, respectively). Patients with hypertension and hirsutism had lower QOL scores (p\u2009&lt;\u20090.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2019-0345_s_996_w2aab3b7c11b1b6b1aab1c17b4Aa\">\n                  <jats:title id=\"d679415e39395_w2aab3b7c11b1b6b1aab1c17b4aAa\">Conclusions<\/jats:title>\n                  <jats:p>HRQOL was relatively more affected in CAH patients with older age, poor hormonal control, high frequency of hospital admissions and those who developed complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2019-0345","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T09:01:41Z","timestamp":1580461301000},"page":"295-304","source":"Crossref","is-referenced-by-count":18,"title":["Assessment of health-related quality of life in Egyptian children and adolescents with congenital adrenal hyperplasia"],"prefix":"10.1515","volume":"33","author":[{"given":"Noha","family":"Musa","sequence":"first","affiliation":[{"name":"Assistant Professor of Pediatric Endocrinology, Diabetes Endocrine and Metabolism Pediatric Unit, Pediatric Department , Cairo University , Cairo , Egypt"},{"name":"home address: 15 Naser El Thawra street, Haram , 12111 Giza , Egypt , Phone: +2 01225304041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Asem","sequence":"additional","affiliation":[{"name":"Department of Public Health , Cairo University , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaza","family":"Basyony","sequence":"additional","affiliation":[{"name":"Pediatric resident at Diabetes Endocrine and Metabolism Pediatric Unit , Cairo University , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Fawaz","sequence":"additional","affiliation":[{"name":"Professor of Pediatric Endocrinology, Diabetes Endocrine and Metabolism Pediatric Unit , Cairo University , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"key":"2023040101034608281_j_jpem-2019-0345_ref_001_w2aab3b7c11b1b6b1ab1b6b1Aa","doi-asserted-by":"crossref","unstructured":"Barcaccia B, Esposito G, Matarese M, Bertolaso M, Elvira M, et al. Defining quality of life: a wild-goose chase? Eur J Psychol 2013;9:185\u2013203.","DOI":"10.5964\/ejop.v9i1.484"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_002_w2aab3b7c11b1b6b1ab1b6b2Aa","doi-asserted-by":"crossref","unstructured":"Groupt W. Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res 1993;2:153\u20139.","DOI":"10.1007\/BF00435734"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_003_w2aab3b7c11b1b6b1ab1b6b3Aa","unstructured":"Ginalska-Malinowska M. Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency \u2013 the next disease included in the neonatal screening program in Poland. Dev Period Med 2018;22:197\u2013200."},{"key":"2023040101034608281_j_jpem-2019-0345_ref_004_w2aab3b7c11b1b6b1ab1b6b4Aa","doi-asserted-by":"crossref","unstructured":"White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245\u201391.","DOI":"10.1210\/edrv.21.3.0398"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_005_w2aab3b7c11b1b6b1ab1b6b5Aa","doi-asserted-by":"crossref","unstructured":"Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011;32:81\u2013151.","DOI":"10.1210\/er.2010-0013"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_006_w2aab3b7c11b1b6b1ab1b6b6Aa","doi-asserted-by":"crossref","unstructured":"Gidl\u00f6f S, Falhammar H, Thil\u00e9n A, von D\u00f6beln U, Ritz\u00e9n M, et al. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol 2013;1:35\u201342.","DOI":"10.1016\/S2213-8587(13)70007-X"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_007_w2aab3b7c11b1b6b1ab1b6b7Aa","doi-asserted-by":"crossref","unstructured":"Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2018;103:4043\u201388.","DOI":"10.1210\/jc.2018-01865"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_008_w2aab3b7c11b1b6b1ab1b6b8Aa","doi-asserted-by":"crossref","unstructured":"Nordenstr\u00f6m A, Falhammar H. Management of endocrine disease: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency. Eur J Endocrinol 2019;180:r127\u201345.","DOI":"10.1530\/EJE-18-0712"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_009_w2aab3b7c11b1b6b1ab1b6b9Aa","doi-asserted-by":"crossref","unstructured":"Bachelot A, Chakthoura Z, Rouxel A, Dulon J, Touraine P.  Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults. Horm Res Paediatr 2008;69:203\u201311.","DOI":"10.1159\/000113020"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_010_w2aab3b7c11b1b6b1ab1b6c10Aa","doi-asserted-by":"crossref","unstructured":"Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, et al. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 2010;95:5110\u201321.","DOI":"10.1210\/jc.2010-0917"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_011_w2aab3b7c11b1b6b1ab1b6c11Aa","doi-asserted-by":"crossref","unstructured":"Daae E, Feragen KB, Nermoen I, Falhammar H. Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review. Endocrine 2018;62:3\u201313.","DOI":"10.1007\/s12020-018-1723-0"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_012_w2aab3b7c11b1b6b1ab1b6c12Aa","doi-asserted-by":"crossref","unstructured":"Gilban DL, Alves Junior PA, Beserra IC. Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil. Health Qual Life Outcomes 2014;12:107.","DOI":"10.1186\/s12955-014-0107-2"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_013_w2aab3b7c11b1b6b1ab1b6c13Aa","unstructured":"Tanner JM. Growth at adolescence, 2nd ed. Oxford, England: Blackwell Scientific, 1962."},{"key":"2023040101034608281_j_jpem-2019-0345_ref_014_w2aab3b7c11b1b6b1ab1b6c14Aa","unstructured":"Prader A. Genital findings in the female pseudo- hermaphroditism of the congenital adrenogenital syndrome; morphology, frequency, development and heredity of the different genital forms. Helv Paediatr Acta 1954;9:231\u201348."},{"key":"2023040101034608281_j_jpem-2019-0345_ref_015_w2aab3b7c11b1b6b1ab1b6c15Aa","doi-asserted-by":"crossref","unstructured":"Yau M, Vogiatzi M, Lewkowitz-Shpuntoff A, Nimkarn S, Lin-Su K. Health-related quality of life in children with congenital adrenal hyperplasia. Horm Res Paediatr 2015;84:165\u201371.","DOI":"10.1159\/000435855"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_016_w2aab3b7c11b1b6b1ab1b6c16Aa","doi-asserted-by":"crossref","unstructured":"Sanches SA, Wiegers TA, Otten BJ, Claahsen-Van Der Grinten HL. Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population. Int J Pediatr Endocrinol 2012;2012:2.","DOI":"10.1186\/1687-9856-2012-2"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_017_w2aab3b7c11b1b6b1ab1b6c17Aa","doi-asserted-by":"crossref","unstructured":"Halper A, Hooke MC, Gonzalez-Bolanos MT, Vanderburg N, Tran TN, et al. Health-related quality of life in children with congenital adrenal hyperplasia. Health Qual Life Outcomes 2017;15:194.","DOI":"10.1186\/s12955-017-0769-7"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_018_w2aab3b7c11b1b6b1ab1b6c18Aa","doi-asserted-by":"crossref","unstructured":"Mueller SC, Ng P, Sinaii N, Leschek EW, Green-Golan L, et al. Psychiatric characterization of children with genetic causes of hyperandrogenism. Eur J Endocrinol 2010;163:801\u201310.","DOI":"10.1530\/EJE-10-0693"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_019_w2aab3b7c11b1b6b1ab1b6c19Aa","unstructured":"Liang HY, Chang HL, Chen CY, Chang PY, Lo FS, et al. Psychiatric manifestations in young females with congenital adrenal hyperplasia in Taiwan. Chang Gung Med J 2008;31:66\u201373."},{"key":"2023040101034608281_j_jpem-2019-0345_ref_020_w2aab3b7c11b1b6b1ab1b6c20Aa","doi-asserted-by":"crossref","unstructured":"Wang C, Tian Q. The investigation of quality of life in 87 Chinese patients with disorders of sex development. BioMed Res Int Volume 2015. Article ID 342420, 6 pages. https:\/\/doi.org\/10.1155\/2015\/342420.","DOI":"10.1155\/2015\/342420"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_021_w2aab3b7c11b1b6b1ab1b6c21Aa","doi-asserted-by":"crossref","unstructured":"Engberg H, Butwicka A, Nordenstr\u00f6m A, Hirschberg AL, Falhammar H, et al. Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: a total population study. Psychoneuroendocrinology 2015;60:195\u2013205.","DOI":"10.1016\/j.psyneuen.2015.06.017"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_022_w2aab3b7c11b1b6b1ab1b6c22Aa","doi-asserted-by":"crossref","unstructured":"Zainuddin AA, Grover SR, Shamsuddin K, Mahdy ZA. Research on quality of life in female patients with congenital adrenal hyperplasia and issues in developing nations. J Pediatr Adolesc Gynecol 2013;26:296\u2013304.","DOI":"10.1016\/j.jpag.2012.08.004"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_023_w2aab3b7c11b1b6b1ab1b6c23Aa","doi-asserted-by":"crossref","unstructured":"Falhammar H, Butwicka A, Land\u00e9n M, Lichtenstein P, Nordenskj\u00f6ld A, et al. Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2014;99:E554\u201360.","DOI":"10.1210\/jc.2013-3707"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_024_w2aab3b7c11b1b6b1ab1b6c24Aa","doi-asserted-by":"crossref","unstructured":"Crawford JM, Warne G, Grover S, Southwell BR, Hutson JM. Results from a pediatric surgical centre justify early intervention in disorders of sex development. J Pediatr Surg 2009;44:413\u20136.","DOI":"10.1016\/j.jpedsurg.2008.10.101"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_025_w2aab3b7c11b1b6b1ab1b6c25Aa","doi-asserted-by":"crossref","unstructured":"Idris AN, Chandran V, Zulkifli SZ, Rasat R. Behavioural outcome in children with congenital adrenal hyperplasia: experience of a single Centre. Int J Endocrinol 2014;2014:483718.","DOI":"10.1155\/2014\/483718"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_026_w2aab3b7c11b1b6b1ab1b6c26Aa","doi-asserted-by":"crossref","unstructured":"Fagerholm R, Mattila AK, Roine RP, Sintonen H, Taskinen S. Mental health and quality of life after feminizing genitoplasty. J Pediatr Surg 2012;47:747\u201351.","DOI":"10.1016\/j.jpedsurg.2011.08.018"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_027_w2aab3b7c11b1b6b1ab1b6c27Aa","doi-asserted-by":"crossref","unstructured":"Warne G, Grover S, Hutson J. A long-term outcome study of intersex conditions. J Pediatr Endocrinol Metab 2005;18:555\u201367.","DOI":"10.1515\/JPEM.2005.18.6.555"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_028_w2aab3b7c11b1b6b1ab1b6c28Aa","doi-asserted-by":"crossref","unstructured":"Berenbaum SA, Bryk KK, Duck SC, Resnick SM. Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 2004;144:741\u20136.","DOI":"10.1016\/j.jpeds.2004.03.037"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_029_w2aab3b7c11b1b6b1ab1b6c29Aa","doi-asserted-by":"crossref","unstructured":"Johannsen TH, Ripa CP, Mortensen EL. Quality of life in 70 women with disorders of sex development. Eur J Endocrinol 2006;155:877\u201385.","DOI":"10.1530\/eje.1.02294"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_030_w2aab3b7c11b1b6b1ab1b6c30Aa","doi-asserted-by":"crossref","unstructured":"Johannsen TH, Ripa CP, Reinisch JM, Schwartz M, Mortensen EL, et al. Impaired cognitive function in women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2006;91:1376\u201381.","DOI":"10.1210\/jc.2005-1959"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_031_w2aab3b7c11b1b6b1ab1b6c31Aa","doi-asserted-by":"crossref","unstructured":"Savanelli A, Alicchio F, Esposito C. A modified approach for feminizing genitoplasty. World J Urol 2008;26:517\u201320.","DOI":"10.1007\/s00345-008-0298-4"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_032_w2aab3b7c11b1b6b1ab1b6c32Aa","doi-asserted-by":"crossref","unstructured":"New MI. An update of congenital adrenal hyperplasia. Ann NY Acad Sci 2004;1038:14\u201343.","DOI":"10.1196\/annals.1315.009"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_033_w2aab3b7c11b1b6b1ab1b6c33Aa","doi-asserted-by":"crossref","unstructured":"Cull ML. A support group\u2019s perspective. Br Med J 2005;330:341.","DOI":"10.1136\/bmj.38365.883843.79"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_034_w2aab3b7c11b1b6b1ab1b6c34Aa","doi-asserted-by":"crossref","unstructured":"Nordenskj\u00f6ld A, Holmdahl G, Fris\u00e9n L, Falhammar H, Filipsson H, et al. Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2008;93:380\u20136.","DOI":"10.1210\/jc.2007-0556"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_035_w2aab3b7c11b1b6b1ab1b6c35Aa","doi-asserted-by":"crossref","unstructured":"Passerini-Glazel G. Feminizing genitoplasty. J Urol 1999;161:1592.","DOI":"10.1016\/S0022-5347(05)68987-2"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_036_w2aab3b7c11b1b6b1ab1b6c36Aa","doi-asserted-by":"crossref","unstructured":"Schnitzer JJ, Donahoe PK. Surgical treatment of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001;30:137\u201354.","DOI":"10.1016\/S0889-8529(08)70023-9"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_037_w2aab3b7c11b1b6b1ab1b6c37Aa","doi-asserted-by":"crossref","unstructured":"Farkas A, Chertin B. Feminizing genitoplasty in patients with 46XX congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2001;14:713\u201322.","DOI":"10.1515\/JPEM.2001.14.6.713"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_038_w2aab3b7c11b1b6b1ab1b6c38Aa","doi-asserted-by":"crossref","unstructured":"Rink RC, Metcalfe PD, Cain MP. Use of the mobilized sinus with total urogenital mobilization. J Urol 2006;176:2205\u201311.","DOI":"10.1016\/j.juro.2006.07.078"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_039_w2aab3b7c11b1b6b1ab1b6c39Aa","doi-asserted-by":"crossref","unstructured":"Braga LH, Pippi-Salle JL. Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment. Eur J Pediatr Surg 2009;19:203\u201310.","DOI":"10.1055\/s-0029-1233490"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_040_w2aab3b7c11b1b6b1ab1b6c40Aa","doi-asserted-by":"crossref","unstructured":"Falhammar H, Nystr\u00f6m HF, Thor\u00e9n M. Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia. Endocrine 2014;47:299\u2013307.","DOI":"10.1007\/s12020-013-0161-2"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_041_w2aab3b7c11b1b6b1ab1b6c41Aa","doi-asserted-by":"crossref","unstructured":"Falhammar H, Claahsen-van der Grinten H, Reisch N, Slowikowska-Hilczer J, Nordenstr\u00f6m A, et al. Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study. Endocr Connect 2018;7:466\u201378.","DOI":"10.1530\/EC-18-0031"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_042_w2aab3b7c11b1b6b1ab1b6c42Aa","doi-asserted-by":"crossref","unstructured":"Arlt W, Krone N. Adult consequences of congenital adrenal hyperplasia. Horm Res 2007;68:158\u201364.","DOI":"10.1159\/000110615"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_043_w2aab3b7c11b1b6b1ab1b6c43Aa","doi-asserted-by":"crossref","unstructured":"Mnif MF, Kamoun M, Mnif F, Charfi N, Kallel N, et al. Long-Term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Am J Med Sci 2012;344:363\u201373.","DOI":"10.1097\/MAJ.0b013e31824369e4"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_044_w2aab3b7c11b1b6b1ab1b6c44Aa","doi-asserted-by":"crossref","unstructured":"Kamoun M, Feki MM, Sfar MH, Abid M. Congenital adrenal hyperplasia: treatment and outcomes. Indian J Endocrinol Metab 2013;17:14\u20137.","DOI":"10.4103\/2230-8210.119491"},{"key":"2023040101034608281_j_jpem-2019-0345_ref_045_w2aab3b7c11b1b6b1ab1b6c45Aa","doi-asserted-by":"crossref","unstructured":"Han TS, Krone N, Willis DS, Conway GS, Hahner S, et al.  Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). Eur J Endocrinol 2013;168:887\u201393.","DOI":"10.1530\/EJE-13-0128"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/jpem\/33\/2\/article-p295.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0345\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0345\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T17:44:26Z","timestamp":1680371066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0345\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,5]]},"published-print":{"date-parts":[[2020,2,25]]}},"alternative-id":["10.1515\/jpem-2019-0345"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2019-0345","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}